SCHEMBL19919639

SCHEMBL19919639

Cc1cc(C)cc(-c2ccc3c4ccccc4n(-c4cc(C#N)c(-c5cc(C)nc(C)c5)cc4-n4c5ccccc5c5ccc(-c6cc(C)cc(C)c6)cc54)c3c2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 1/20 0.33
GRIN2B Q13224 1/20 0.33
KDM5B Q9UGL1 1/20 0.33
NPSR1 Q6W5P4 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 2/20 0.32
GLA P06280 1/20 0.32
HPGD P15428 1/20 0.32
MAPK1 P28482 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MAT2A P31153 1/20 0.31
BRD9 Q9H8M2 1/20 0.31
BRD7 Q9NPI1 1/20 0.31
PHGDH O43175 1/20 0.31
IMPDH2 P12268 1/20 0.31
GRM2 Q14416 1/20 0.31
METAP2 P50579 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19919637 0.94 KDM5B (0.35) GRIN1GRIN2BKDM5BMETAP2
SCHEMBL19913242 0.94 GRIN1 (0.33) GRIN1GRIN2BKDM5BNPSR1CYP1A2
SCHEMBL19919838 0.93 MAOA (0.34) NPSR1CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL19913212 0.91 CYP1A2 (0.38) NPSR1CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL23487749 0.91 GRIN1 (0.33) GRIN1GRIN2BKDM5BNPSR1CYP1A2
SCHEMBL19909088 0.91 IRAK4 (0.32) NPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL19919635 0.90 ALDH1A1 (0.32) NPSR1CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL19919816 0.89 CHEK1 (0.37) NPSR1CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL19909138 0.89 GRM2 (0.37) NPSR1CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL19919841 0.89 KDM5B (0.35) GRIN1GRIN2BKDM5BMETAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 GRIN1 1676/4885GRIN2B 447/4885KDM5B 4454/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 GRIN1 2896/4885GRIN2B 2390/4885KDM5B 4185/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 GRIN1 1676/4885GRIN2B 447/4885KDM5B 4454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.